Comparing 2 different modalities for treament of parotid sialocele in postoperative oral squamous cell carcinoma

Comparing the efficacy of 3% NACL with pressure dressing and oral/rt glycopyrrolate with pressure dressing in the treatment of parotid sialocele, in postoperative oral squamous cell carcinoma patient- a randomised control trial - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/068599

Enrollment

Registered

2024-06-07

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K114- Fistula of salivary gland

Interventions

Intervention1: Use of 3% Nacl with pressure dressing in treatment of parotid sialocele in postoperative Oral squamous cell carcinoma: 60 degree hypertonic saline of 5 ml will be injected at parotid si

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients operated for Oral squamous Cell carcinoma(buccal and GB sulcus) with resection of tail of Parotid followed by Reconstruction using suitable flap. 2. Patients with excessive salivation postoperatively in patients operated for Oral squamous cell carcinoma

Exclusion criteria

Exclusion criteria: 1. Systemic or autoimmune diseases affecting the salivary glands 2. Patients with any salivary gland neoplasms or inflammatory disorders. 3. Patients that have been previously operated for Oral squamous cell carcinoma. 4. Patients presenting with Recurrence of Oral squamous cell carcinoma. 5. Patients with traumatic injuries to the salivary gland region

Design outcomes

Primary

Measure	Time frame
The superior efficacy of 3% NaCl with pressure dressing over oral glycopyrrolate with pressure dressing in resolving parotid sialocele among postoperative oral squamous cell carcinoma (OSCC) patients.Timepoint: Assesment will be done at the 12 and 24 months	—

Secondary

Measure	Time frame
NILTimepoint: NA	—

Countries

India

Contacts

Public ContactDrDeepankar Shukla

Datta Meghe Institute of Higher Education and Research

dr.deepankarshukla@gmail.com9925534891

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026